Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., has grown its member ecosystem through new collaborations with the CHU of Limoges in France and TBS GB in the United Kingdom. The CHU of Limoges (Centre Hospitalier Universitaire de Limoges) leverages Qualcomm Life’s CE-listed and Continua Certified 2net Platform and Hub to serve as the biometric data connectivity infrastructure for its ICARE chronic care management program in France. TBS GB, a leading health care technology management service provider in the United Kingdom, is also using the 2net Platform in telehealth programs and has already seen compelling results with improved health outcomes and patient satisfaction.
ICARE is a large-scale pilot project that aims to evaluate the medico-social, economic, and organizational impacts of home health technology solutions for at-risk patient populations living in rural areas, focused specifically on avoiding and reducing hospital readmissions. The CHU of Limoges deployed its connected health services in 550 homes in rural regions including Corrèze, Creuse, Haute-Vienne and Loir-et-Cher, where 45% of the patient population is aged 65 or older to measure the benefits of connected health when there is lower access to traditional care services. ICARE leverages the robust 2net Connectivity Platform and Hub to enable seamless remote monitoring capabilities, allowing general practitioners and nurses to stratify patients, coordinate care and keep patients living at home longer.
“We recognize Qualcomm Life as a true leader in the connected health space, and have selected their 2net technology because it offers unprecedented interoperability and is device agnostic,” states Professor Thierry Dantoine, head of the geriatric unit at the Limoges Centre Hospitalier Universitaire (University Hospital) (CHU). “Qualcomm Life’s solution offers a flexible, secure enterprise grade solution that will enable us to scale our offering, ultimately helping more patients better manage their long-term conditions.”
TBS GB, a subsidiary of TBS Group, operates in the United Kingdom and specializes in the management of health care technology, provides telehealth technology and logistics support to Orla Healthcare, a private provider of home health services, in integrated care pilots in the United Kingdom. Focused on streamlining transitions of care, their first pilot with 400 patients saved 2000 hospital bed-stays, had zero unavoidable readmissions and saw a 99% patient satisfaction rating. Patients in the pilot were admitted to NHS hospital, Princess Alexandra Hospital (PAH), located in Harlow, UK, but treatment was provided at home with a telemedicine kit comprised of a blood pressure monitor, a pulse oximeter, a telecare device (GPS location system and alarm button) and a 2net Hub to capture and transmit biometric data from the patient’s home to the 24/7 clinical support team. The patient data was visualized using Medixine Clinic, a cloud-based software program that enables biometric data visualization, triage management, and at-risk patient population management.
“For years mobile health has remained a nascent category with small-scale deployments and little evidence capture,” explains Laurent Vandebrouck, senior director of Qualcomm Life in Europe. “The strong outcomes data we are seeing from our collaboration with TBS GB and Medixine is one of many examples where a clear ROI is demonstrated by using connected health technologies.”
TBS GB and Orla Healthcare have now extended the pilot to include early discharge of ward patients, transitioning in-patients from hospital wards and treating them at home. This service is unique within the NHS and is made possible by Orla’s consultant led team and TBS GB’s technology solutions enabled by 2net.
Qualcomm Life has grown its ecosystem to nearly 500 member companies in the U.S. and Europe, comprised of leading pharmaceuticals, telehealth service providers, medical device manufacturers and more. By leveraging Qualcomm Life’s 2net Platform, 2net Hub and 2net Mobile, these companies now have access to one of the largest open and interoperable connected health ecosystems globally.
Qualcomm Life to Have Significant Presence at Mobile World Congress 2015
Qualcomm Life will showcase chronic care, transitional care and connected therapy management solutions at booth #E310 in Hall 3 of the Fira Gran Via and will be speaking throughout the week:
- Rick Valencia, senior vice president and general manager, Qualcomm Life, will participate on a panel, “Health and Education for Connected Citizens,” on Tuesday, March 3rd from 4:00 – 5:30 pm CET.
- Rick Valencia will keynote titled, “Wearables Across the Spectrum
of Care: From Prevention to Intervention” on Wednesday, March 4th from 2:20 – 2:40 pm CET
- James Mault, MD F.A.C.S., vice president and chief medical officer, Qualcomm Life, will participate in a panel on Tuesday, March 3rd at 1:50 pm CET titled, “mHealth for Chronic Diseases and Active and Healthy Ageing.”
- Qualcomm Life will be hosting an industry roundtable focused on “How Connected Health is Achieving Scale” with telehealth thought leaders on Wednesday, March 4th from 10:30 am – 1:30 pm CET.
About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 25 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.
 over 2,000 households in 4 departments